Asia Business & Finance Roundup - Reverse Mergers and Alternative IPOs
The Roundup monthly meetings cover Pan-Asia business topics including M&A, venture capital, foreign direct investment & sovereign wealth funds for high-tech, cleantech, telecom, biotech and nanotech industries in Japan, China, India & the rest of Asia.
Join our panel of experts as they discuss reverse mergers and self-financings as an alternative to traditional IPO's. Recent rule changes and developments in the market cause these transactions have become more complex. The discussion will include the pro and cons of reverse mergers in this market and the sky rocketing growth of reverse mergers in China.
- Chris Reinhard, President & CEO, Cardium Therapeutics
- Jamie Mercer, Partner, Sheppard Mullin
- Robert Stephenson, Vice President - Corporate Finance, Roth Capital
Wednesday, August 18, 2010
6:00 - 8:00 p.m.
Sheppard Mullin Richter & Hampton LLP
12275 El Camino Real, Suite 200
San Diego, CA 92130
Please contact Amy Romaker, firstname.lastname@example.org or (858) 720-7403